Here are the most clinically significant terms and keywords extracted from the guideline, organized by category for clarity:

### **1. Definitions & Key Conditions**  
- **Hypertensive disorders of pregnancy**  
- **Chronic hypertension** (present at booking or before 20 weeks)  
- **Gestational hypertension** (new hypertension after 20 weeks, no significant proteinuria)  
- **Pre-eclampsia** (new hypertension after 20 weeks + significant proteinuria)  
- **Severe pre-eclampsia** (pre-eclampsia + severe hypertension/symptoms)  
- **Eclampsia** (convulsions associated with pre-eclampsia)  
- **HELLP syndrome** (haemolysis, elevated liver enzymes, low platelets)  

### **2. Blood Pressure & Proteinuria Assessment**  
- **Hypertension thresholds**:  
  - **Mild-moderate**: 140/90–159/109 mmHg  
  - **Severe**: ≥160/110 mmHg  
- **Proteinuria assessment**:  
  - **Reagent-strip reading device** (avoid first morning void)  
  - **Urinary protein:creatinine ratio (PCR)**  

### **3. Risk Factors for Pre-eclampsia**  
- **Moderate risk**:  
  - Maternal age ≥40  
  - Nulliparity  
  - Family history of pre-eclampsia  
  - BMI ≥35  
- **High risk**:  
  - Chronic hypertension  
  - Previous hypertensive disorder in pregnancy  
  - Chronic kidney disease  
  - Autoimmune disease (e.g., SLE)  
  - Diabetes  

### **4. Monitoring & Management**  
- **Antenatal care for high-risk women**:  
  - **Uterine artery Dopplers**  
  - **Serial ultrasounds**  
  - **BP monitoring + urinalysis every 2 weeks from 28 weeks**  
  - **CTG if reduced fetal movements**  
- **Symptoms of pre-eclampsia**:  
  - Severe headache  
  - Vision problems  
  - Rib pain  
  - Vomiting  
  - Sudden swelling  

### **5. Treatment & Targets**  
- **Antihypertensive medications**:  
  - **Labetalol (first-line)**  
  - **Nifedipine**  
  - **Methyldopa**  
- **Target BP**: ≤135/85 mmHg  
- **Avoid certain medications in pregnancy**  

